Every year, a considerable portion of the company profit is re-invested by Greiner Bio-One in the area of research and development. Both user and patient profit directly from product innovations “made by Greiner Bio-One”. In this way, the virtually unbreakable VACUETTE® System has made the blood collection procedure safer, the risk of infection having been reduced drastically. Current product innovations include PapilloCheck and the GBO SCS Saliva Collection System.
PapilloCheck is a DNA Biochip that can help to detect cervical cancer at an early stage. Different types of virus can be determined, ensuring that a better risk evaluation for the patient is made possible.
The new GBO SCS Saliva Collection and Quantification System simplifies sample collection, for whenever it is important to collect material for testing on site, quickly, and without specialised knowledge. The system is for example particularly suitable for roadside testing, as saliva for testing can be taken from the driver quickly and pain-free.